Disclosure: I am short OPK. (More…) When I first raised the alarm about Ziopharm Oncology (ZIOP), I received death threats and threats of lawsuits from many retail investors. Some of these can still be found posted online. Many retail investors were so enthralled with this “guaranteed winner” that any suggestion to sell by anyone at any price was shouted down…

Read More

  Shares of Opko Health (OPK) have risen 65% in the past three months as a string of domestic and international acquisitions, along with a greater collaboration with Bristol Meyers (BMY), has opened up numerous new pathways for the company. Opko’s prospects as a company continue to be bright, however at the current price of…

Read More